Combivir Market: Current Analysis and Forecast (2023-2030)
Emphasis on Type (Branded and Generic); Application (Nonoccupational Exposure and Occupational Exposure); and Region/Country
The Global Combivir Market is expected to grow at a significant rate of around 3% during the forecast period. Combivir is a drug made with a combination of Lamivudine and zidovudine and is used as an antiretroviral agent against the human immunodeficiency virus. Combivir mainly gained prominence due to the increased cases of AIDS (acquired immunodeficiency syndrome) globally. For instance, an estimated 1.2 million people in the U.S. had HIV at the end of 2021 as reported by the Centers for Disease Control and Prevention, which is the national public health agency of the U.S. In addition to this, investments in healthcare departments as well as government awareness programs regarding HIV/AIDS have increased significantly in recent years, which are the key factors that are creating opportunities for the market. For instance, the U.S. launched the Sexually Transmitted Infections National Strategic Plan to reverse the recent dramatic surge in STIs. The goal is to use health education at schools, among other professionals, and families to prevent STIs and help adolescents make informed, positive, and safe choices about healthy relationships, safe sexual activity, and their reproductive health.
Mylan Inc.; Macleods Pharmaceuticals Ltd.; Lupin; Aurobindo Pharma; Pfizer Inc.; Cipla Inc.; ViiV Healthcare group of companies; Hetero; Strides Pharma Science Limited; GSK plc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst type, generic category to witness higher CAGR during the forecast period”
Based on type, the market is bifurcated into branded and generic. The generic segment is expected to grow with a high CAGR during the forecast period as it is the cost-effective alternative to branded drugs. They are easily available in maximum regions and are easy on pockets for people in middle to low-income countries. For instance, in 2022, the Association for Accessible Medicines released U.S. Generic and Biosimilar Medicines Savings Report where generic and biosimilar drugs were reported to generate a record USD 373 billion for America’s patients and healthcare system in 2021. Thus, the generic category is expected to witness higher CAGR during the forecast period.
“Amongst application, nonoccupational exposure held a significant share in the market in 2022”
Based on application, the market is bifurcated into nonoccupational exposure and occupational exposure. The nonoccupational exposure segment dominated the market in 2022 owing to the lack of awareness regarding the mode of transmission of HIV. Additionally, there have been increased incidences of unsafe sexual intercourse among adolescents globally which is a driving factor for this segment. For instance, according to the U.S.-based National Youth Risk Behavior Survey, 2021, 30% of high school students were involved in sexual activities out of which 48% reported having unprotected sexual intercourse. Thus, the nonoccupational exposure segment held a significant share of the market in the year 2022.
“Amongst regions, APAC region is expected to grow with a high CAGR during the forecast period”
For a better understanding of the market adoption of combivir, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is expected to grow with a high CAGR during the forecast period. Several factors such as a surge in drug addiction among adults and adolescents in the region. For example, the Ministry of Home Affairs of India reported the highest number of drug addiction cases in Uttar Pradesh (31,482) followed by Maharashtra (28,959), and Punjab (28417) in the period of 2019 to 2021. Further, the increase in incidences of HIV/AIDS, the development of a wide range of therapeutics with combivir, enhanced accessibility of pharmaceutical products, the presence of key generic pharmaceutical companies in the region, and the surge in government initiatives and special communities are also having a positive impact on the market’s growth. Hence, the APAC region is supposed to witness a higher CAGR during the forecast period.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global combivir market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Combivir Market Analysis (2023-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global combivir market were the three major steps undertaken to create and analyze the adoption of combivir in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global combivir market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the combivir market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the combivir market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, application, and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the combivir market. Further, we conducted factor analysis using dependent and independent variables such as type, application, and regions of combivir. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the combivir market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global combivir market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 00for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the combivir market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global combivir market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global combivir market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of type, application, and regions in the global combivir market.
The main objective of the Global Combivir Market Study
The current & future market trends of the global combivir market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the combivir market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of type, application, and regions
- Define and analyze the regulatory framework for the combivir industry.
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
- Analyze the current and forecast market size of the combivir market for the major region.
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
- Company profiles of the combivir market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Frequently Asked Questions FAQs
Q1: What is the current market size and growth potential of the combivir market?
Q2: What are the driving factors for the growth of the combivir market?
Q3: Which segment has the largest share of the combivir market by type?
Q4: What are the emerging technologies and trends in the combivir market?
Q5: Which region will dominate the combivir market?
Q6: Who are the key players operating in the combivir market?
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
